White & Case secures $405M jury win for Regeneron in antitrust case, with Amgen found liable for anti-competitive bundling ...

NICE has issued a final appraisal determination recommending Celgene's Otezla for adults with active psoriatic arthritis, reversing an earlier decision to reject the drug. The oral drug is Celgene ...

Xeljanz has been FDA-approved since 2012 for rheumatoid arthritis as a twice-daily pill ... These include Celgene’s Otezla (apremilast), which like Xeljanz offers a convenient oral alternative ...